日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Transcriptomic analysis identifies a potential target for bevacizumab resistant glioblastoma

转录组分析发现了一种贝伐珠单抗耐药性胶质母细胞瘤的潜在靶点

Roshan Lodha ,Gaelle Muller-Greven ,Muhammad Asad Maqbool ,Lydia Guo ,Graham Buchan ,Kailash Singh ,Maha A Qadan ,Vipin Shankar Chelakkot ,Paul A Decker ,Katrina Bakken ,Brett L Carlson ,Danielle Burgenske ,Amy S Nowacki ,George Vasmatzis ,Sani H Kizilbash ,Jann N Sarkaria ,Candece L Gladson

PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation

PPM1D 突变是新生弥漫性中线胶质瘤形成的致癌驱动因素

Prasidda Khadka #, Zachary J Reitman #, Sophie Lu, Graham Buchan, Gabrielle Gionet, Frank Dubois, Diana M Carvalho, Juliann Shih, Shu Zhang, Noah F Greenwald, Travis Zack, Ofer Shapira, Kristine Pelton, Rachel Hartley, Heather Bear, Yohanna Georgis, Spandana Jarmale, Randy Melanson, Kevin Bonanno, K

Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma

神经元分化和细胞周期程序介导 MYC 驱动的髓母细胞瘤对 BET-溴结构域抑制的反应

Pratiti Bandopadhayay, Federica Piccioni, Ryan O'Rourke, Patricia Ho, Elizabeth M Gonzalez, Graham Buchan, Kenin Qian, Gabrielle Gionet, Emily Girard, Margo Coxon, Matthew G Rees, Lisa Brenan, Frank Dubois, Ofer Shapira, Noah F Greenwald, Melanie Pages, Amanda Balboni Iniguez, Brenton R Paolella, Al